+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Oncogene"

Gene Amplification Technologies Market Report 2023-2033 - Product Thumbnail Image

Gene Amplification Technologies Market Report 2023-2033

  • Report
  • December 2022
  • 425 Pages
  • Global
From
Cell and Gene Therapy World Market and Market Potential - Product Thumbnail Image

Cell and Gene Therapy World Market and Market Potential

  • Report
  • February 2022
  • 272 Pages
  • Global
From
Precision Cancer Therapeutics, 2022 - Product Thumbnail Image

Precision Cancer Therapeutics, 2022

  • Report
  • November 2022
  • 154 Pages
  • Global
From
From
Lumakras Drug Clinical Insight & Sales Forecast 2026 - Product Thumbnail Image

Lumakras Drug Clinical Insight & Sales Forecast 2026

  • Report
  • July 2021
  • 60 Pages
  • Global
From
From
Global Spatial Genomics and Transcriptomics Market - Product Thumbnail Image

Global Spatial Genomics and Transcriptomics Market

  • Report
  • March 2023
  • 157 Pages
  • Global
From
Exosome Diagnostics and Therapeutics: Global Markets 2021-2026 - Product Thumbnail Image

Exosome Diagnostics and Therapeutics: Global Markets 2021-2026

  • Report
  • November 2021
  • 255 Pages
  • Global
From
From
Serine/Threonine Protein Kinase A Raf - Pipeline Review, H1 2020 - Product Thumbnail Image

Serine/Threonine Protein Kinase A Raf - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 34 Pages
  • Global
From
From
FTase (Farnesyltransferase) inhibitor- Pipeline Insight, 2024 - Product Thumbnail Image

FTase (Farnesyltransferase) inhibitor- Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
ROZLYTREK Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ROZLYTREK Market Drug Insight and Market Forecast - 2032

  • Report
  • February 2023
  • 30 Pages
  • Global
From
CDK12 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CDK12 Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • March 2024
  • 60 Pages
  • Global
From
Proto oncogene protein c-akt inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto oncogene protein c-akt inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Proto-oncogene protein c mdm2 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto-oncogene protein c mdm2 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Proto oncogene protein c-myc inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto oncogene protein c-myc inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 96 Pages
  • Global
From
Loading Indicator

The Oncogene market is a subset of the Genomics market that focuses on the study of cancer-causing genes. Oncogenes are genes that have the potential to cause cancer when they are mutated or expressed at high levels. Oncogenes are studied to understand the molecular basis of cancer and to develop new treatments. Research in this field has led to the development of targeted therapies, such as monoclonal antibodies, small molecule inhibitors, and gene therapies. The Oncogene market is highly competitive, with many companies developing new technologies and treatments. Companies in the market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Bio-Rad Laboratories. Show Less Read more